Medicine
Merck is making its COVID-19 antiviral pill more affordable to low-income countries
Drug maker Merck has agreed to license a promising antiviral pill to treat COVID-19 to low- and middle-income countries for free.
Cooling caps can help prevent chemo hair loss
Chemo hair loss is a common side effect for cancer patients, but cooling caps can help limit the loss.
HIV treatment gets green light for human trials
Excision BioTherapeutics is cleared to begin human trials of a CRISPR-based HIV treatment that’s administered in just one IV infusion.
Johns Hopkins receives the first NIH grant for clinical psychedelic research in half a century
For the first time in decades, the National Institutes of Health is funding a clinical psychedelic study, perhaps a turning point for the field.
New cardiac patch can be implanted with a syringe
A new cardiac patch developed by Canadian scientists could help repair heart damage by supporting tissue without blocking electrical activity.
WHO recommends its first malaria vaccine
A malaria vaccine developed by GlaxoSmithKline, Mosquirix, has been recommended for use by the World Health Organization.
Pill to treat COVID-19 cuts risk of hospitalization or death in half
A pill to treat COVID-19 that cut hospitalizations and deaths in half could become the first oral medication against the disease.
Antiviral reduces COVID-19 hospitalizations by 87%
The FDA-approved antiviral drug remdesivir prevents high-risk people from ending up in the hospital, if given early.
A malaria antibody prevented infections in purposefully-infected volunteers
In a small study, researchers found an antibody that prevents malaria infection in people purposefully infected with the parasite.
Johns Hopkins has developed a lung cancer blood test
Researchers at Johns Hopkins are using AI to power a lung cancer blood test.